For: | Miedany YE, Gaafary ME, Yassaki AE, Youssef S, Nasr A, Ahmed I. Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 2014; 4(2): 14-21 [DOI: 10.5499/wjr.v4.i2.14] |
---|---|
URL: | https://www.wjgnet.com/2220-3214/full/v4/i2/14.htm |
Number | Citing Articles |
1 |
Yasser El Miedany. New Horizons in Osteoporosis Management. 2022; : 345 doi: 10.1007/978-3-030-87950-1_12
|
2 |
Yasser El Miedany. New Horizons in Osteoporosis Management. 2022; : 297 doi: 10.1007/978-3-030-87950-1_10
|
3 |
Yasser El Miedany. Co-morbidity index in rheumatoid arthritis: time to think. Clinical Rheumatology 2015; 34(12): 1995 doi: 10.1007/s10067-015-3101-0
|
4 |
|
5 |
Y El Miedany, Farhanah Paruk, Asgar Kalla, A. Adebajo, Maha El Gaafary, Abdellah El Maghraoui, Madeleine Ngandeu, Dzifa Dey, Naglaa Gadallah, Mohamed Elwy, Farzana Moosajee, Mohammed Hassan Abu-Zaid, Salwa Galal, Soussen Miladi, Waleed Hassan, Abubaker Fadlelmola, Sally Saber. Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: an initiative by the African Society of Bone Health and Metabolic Bone Diseases. Archives of Osteoporosis 2021; 16(1) doi: 10.1007/s11657-021-01035-z
|
6 |
Yasser El Miedany, Sami Bahlas. New Horizons in Osteoporosis Management. 2022; : 473 doi: 10.1007/978-3-030-87950-1_18
|